Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for cardiovascular research.

R J Lefkowitz1, J T Willerson

  • 1Department of Internal Medicine, University of Texas Medical School, 6431 Fannin, Suite 1.150, Houston, TX 77030, USA.

JAMA
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries.

Circulation·2001
Same author

C-reactive protein: linking inflammation to cardiovascular complications.

Circulation·2001
Same author

Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.

Journal of the American College of Cardiology·2001
Same author

Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy.

Circulation·2001
Same author

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs.

Circulation·2001
Same author

Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2001
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Cardiovascular disease research is advancing rapidly, offering hope for longer, healthier lives. Continued progress in clinical and basic science promises significant improvements for individuals at risk.

Area of Science:

  • Cardiology
  • Clinical Research
  • Basic Science Research

Background:

  • Cardiovascular disease (CVD) represents a major global health challenge.
  • Significant advancements have been made in understanding and treating CVD over the last decade.
  • Numerous opportunities for further breakthroughs exist in cardiovascular research.

Purpose of the Study:

  • To highlight the progress in cardiovascular research.
  • To identify promising areas for future investigation in cardiology.
  • To underscore the potential impact of research on patient outcomes.

Main Methods:

  • Review of recent clinical studies in cardiovascular disease.
  • Analysis of fundamental breakthroughs in basic cardiovascular science.

Related Experiment Videos

  • Synthesis of current research trends and future directions.

    • Main Results:

    • Remarkable progress has been achieved in both clinical and basic cardiovascular research.
    • Several promising avenues for further investigation have been identified.
    • The current pace of research suggests substantial future benefits.

    Conclusions:

    • Ongoing advancements in cardiovascular research are substantial.
    • Future research holds significant promise for improving patient quality of life.
    • Accelerated progress in cardiovascular science is expected to enhance longevity for at-risk populations.